Harmony Biosciences News and Activities

Presence

Harmony Biosciences develops and markets medicines for rare neurological and sleep-related disorders. Its products and services support patients, healthcare providers, and specialty care partners in the United States.

Harmony Biosciences products and services overview:

Rare disease medicines
Sleep disorder treatments
Neurology therapies
Prescription medicines
Patient support services

Revenue: ~$715 million

Employees: 300

Headquarters: Plymouth Meeting, United States (USA)

Harmony Biosciences is one of the...

Harmony Biosciences is a company listed under the stock ticker HRMY (US).

They are in:

Biotechnology50%
Pharmaceuticals50%

Executives

View the org chart displaying its 42 main executives

Most searched biographies at Harmony Biosciences

Popular executive movements at Harmony Biosciences

Glenn Reicin has joined the company as Chief Financial Officer (posted on April 14 2026).
Sandip Kapadia, Chief Financial Officer and Chief Administrative Officer, has left the company (posted on April 14 2026).
Troy Ignelzi has joined the company as Director (posted on April 2 2026).

Click here to view some more movements at Harmony Biosciences

Create your alert
to follow the executive moves at Harmony Biosciences.